Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RSV) vaccine

Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RSV) vaccine

US Patent 10532094 · Granted Jan 14, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and compositions for inducing protective immunity against filovirus infe2024
Recombinant modified vaccinia virus ankara (MVA) equine encephalitis virus vacci2023
Multivalent recombinant modified vaccinia virus ankara (MVA) vector encoding fil2022
Stable recombinant MVA vectors comprising modified RSV genes with reduced intram2022
Methods and compositions for inducing protective immunity against filovirus infe2021
Recombinant modified vaccinia virus Ankara (MVA) foot and mouth disease virus (F2021
PR13.5 promoter for robust T-cell and antibody responses2021
Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RS2021
Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RS2021
Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RS2021
Methods and compositions for inducing protective immunity against a marburg viru2021
Recombinant modified vaccinia virus Ankara (MVA) equine encephalitis virus vacci2021